Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The Xenopus c-mos proto-oncogene product, Mosxe, possesses cytostatic factor (CSF) activity to arrest maturing oocytes in metaphase II and has weak transforming activity in mouse NIH3T3 cells. We show that Mosxe mutants bearing 'stabilizing' penultimate N-terminal amino acids are strongly transforming and can retard progression through the G2-M phases in Mosxe-transformed cells, probably via their CSF activity. On the other hand, a cyclin-Mosxe fusion protein, which undergoes abrupt degradation at the end of mitosis and is restored to its normal levels only after the G1 phase, transforms cells much less efficiently than a mutated cyclin-Mosxe fusion protein that is stable during M-G1 transition. Moreover, in low-serum medium, cells transformed by the unstable cyclin-Mosxe require a long period to enter the S phase, in contrast with the rapid entry into the S phase of cells transformed by the stable cyclin-Mosxe. These results provide strong evidence that unlike the physiological CSF activity, the transforming activity of Mos is exerted in the G1 phase of the cell cycle.
Bernard,
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.
1983, Pubmed
Bernard,
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.
1983,
Pubmed
Bishop,
Molecular themes in oncogenesis.
1991,
Pubmed
Blose,
10-nm filaments are induced to collapse in living cells microinjected with monoclonal and polyclonal antibodies against tubulin.
1984,
Pubmed
Bold,
Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors.
1985,
Pubmed
Cantley,
Oncogenes and signal transduction.
1991,
Pubmed
Chackalaparampil,
Altered phosphorylation and activation of pp60c-src during fibroblast mitosis.
1988,
Pubmed
Ciechanover,
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
1991,
Pubmed
Cross,
Growth factors in development, transformation, and tumorigenesis.
1991,
Pubmed
DePinho,
Structure and expression of the murine N-myc gene.
1986,
Pubmed
Doppler,
Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression.
1987,
Pubmed
Draetta,
Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF.
1989,
Pubmed
Evans,
Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.
1983,
Pubmed
Fischinger,
Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis.
1971,
Pubmed
Freeman,
Effects of the v-mos oncogene on Xenopus development: meiotic induction in oocytes and mitotic arrest in cleaving embryos.
1990,
Pubmed
,
Xenbase
Freeman,
Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes.
1989,
Pubmed
,
Xenbase
Gautier,
Cyclin is a component of maturation-promoting factor from Xenopus.
1990,
Pubmed
,
Xenbase
Glotzer,
Cyclin is degraded by the ubiquitin pathway.
1991,
Pubmed
,
Xenbase
Goldman,
Expression of c-mos RNA in germ cells of male and female mice.
1987,
Pubmed
Graham,
A new technique for the assay of infectivity of human adenovirus 5 DNA.
1973,
Pubmed
Huang,
Specificity of cotranslational amino-terminal processing of proteins in yeast.
1987,
Pubmed
Hunt,
Embryology. Under arrest in the cell cycle.
1989,
Pubmed
,
Xenbase
Hunt,
Cell biology. Destruction's our delight..
1991,
Pubmed
Hunter,
Cooperation between oncogenes.
1991,
Pubmed
Hunter,
Cyclins and cancer.
1991,
Pubmed
Karsenti,
Interconversion of metaphase and interphase microtubule arrays, as studied by the injection of centrosomes and nuclei into Xenopus eggs.
1984,
Pubmed
,
Xenbase
Keshet,
Developmental regulation of ovarian-specific Mos expression.
1988,
Pubmed
Liu,
Cell cycle-mediated structural and functional alteration of P85gag-mos protein kinase activity.
1990,
Pubmed
Masui,
Oocyte maturation.
1979,
Pubmed
Masui,
Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.
1971,
Pubmed
Maxwell,
Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos.
1985,
Pubmed
Minshull,
Translation of cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis.
1989,
Pubmed
,
Xenbase
Morgan,
Mitosis-specific phosphorylation of p60c-src by p34cdc2-associated protein kinase.
1989,
Pubmed
,
Xenbase
Murray,
The role of cyclin synthesis and degradation in the control of maturation promoting factor activity.
1989,
Pubmed
,
Xenbase
Mutter,
Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells.
1987,
Pubmed
Nishizawa,
The 'second-codon rule' and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Nurse,
Universal control mechanism regulating onset of M-phase.
1990,
Pubmed
Okazaki,
Correlation between physiological and transforming activities of the c-mos proto-oncogene product and identification of an essential Mos domain for these activities.
1991,
Pubmed
,
Xenbase
O'Keefe,
The c-mos gene product is required for cyclin B accumulation during meiosis of mouse eggs.
1991,
Pubmed
O'Keefe,
Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg.
1989,
Pubmed
Oskarsson,
Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus.
1980,
Pubmed
Papkoff,
Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.
1982,
Pubmed
Papkoff,
The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein.
1983,
Pubmed
Pardee,
G1 events and regulation of cell proliferation.
1989,
Pubmed
Paules,
Mouse Mos protooncogene product is present and functions during oogenesis.
1989,
Pubmed
,
Xenbase
Perricaudet,
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.
1979,
Pubmed
Propst,
Expression of c-mos proto-oncogene transcripts in mouse tissues.
,
Pubmed
Rechavi,
Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element.
1982,
Pubmed
Reddy,
Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus.
1980,
Pubmed
Rogers,
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.
1986,
Pubmed
Roy,
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product.
1990,
Pubmed
,
Xenbase
Sagata,
The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation.
1989,
Pubmed
,
Xenbase
Sagata,
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs.
1989,
Pubmed
,
Xenbase
Sagata,
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Schmidt,
Chicken homolog of the mos proto-oncogene.
1988,
Pubmed
Shenoy,
Purified maturation promoting factor phosphorylates pp60c-src at the sites phosphorylated during fibroblast mitosis.
1989,
Pubmed
,
Xenbase
Southern,
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
1982,
Pubmed
Taylor,
The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.
1985,
Pubmed
Van Beveren,
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.
1983,
Pubmed
Van Beveren,
FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes.
1984,
Pubmed
Van Beveren,
Nucleotide sequence of the genome of a murine sarcoma virus.
1981,
Pubmed
Vande Woude,
mos proto-oncogene function.
1990,
Pubmed
,
Xenbase
Warren,
Elevated expression of pp60c-src alters a selective morphogenetic property of epithelial cells in vitro without a mitogenic effect.
1988,
Pubmed
Watanabe,
Independent inactivation of MPF and cytostatic factor (Mos) upon fertilization of Xenopus eggs.
1991,
Pubmed
,
Xenbase
Watanabe,
Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs.
1989,
Pubmed
,
Xenbase
Watson,
Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-myc.
1983,
Pubmed
Yasuda,
A point mutation in C-terminal region of cdc2 kinase causes a G2-phase arrest in a mouse temperature-sensitive FM3A cell mutant.
1991,
Pubmed
Yew,
mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.
1991,
Pubmed
,
Xenbase
Zhou,
Ability of the c-mos product to associate with and phosphorylate tubulin.
1991,
Pubmed
,
Xenbase